DOI:

Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?

Watanabe Y., Hayashida K., Lefèvre T., Chevalier B., Hovasse T., Romano M., Garot P., Farge A., Donzeau-Gouze P., Morice M.C.

Risk assesment in TAVI including valve-in-valve

Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?

Aims: The European System for Cardiac Operative Risk Evaluation II (ESII) has been developed recently to improve the predictive value of the original logistic EuroSCORE (LES). The purpose of this study was to examine the performance of the ESII in patients undergoing transcatheter aortic valve implantation (TAVI).

Methods and results: Between October 2006 and November 2011, 453 consecutive patients with severe aortic stenosis undergoing TAVI using both the Edwards valve and CoreValve were included in the current analysis. The performance of ESII, LES and Society of Thoracic Surgeons Predicted Risk of Mortality score (STS) were evaluated. Mean age was 83.1±6.4. The Edwards valve was used in 382 (84.3%) of the cohort. Observed 30-day mortality was 12.8%. The mean ESII, LES and STS were 8.1±5.2, 22.4±12.1, 8.1±6.0, respectively. Moderate correlation was observed in both ESII vs. LES (R=0.65, p<0.01), ESII vs. STS (R=0.47, p<0.01). ESII best predicted 30-day mortality compared to LES and STS (the area under the receiver operating characteristic curve [AUC]: 0.68, 0.65 and 0.60 respectively). In the TF cohort, ESII was better in predicting 30-day mortality compared to LES and STS (AUC=0.74, 0.61, 0.60, respectively).

Conclusions: Although the ESII was inadequately calibrated for predicting 30-day mortality, the ESII demonstrated better predictive performance after TAVI compared to the LES and STS especially in the TF cohort.

Volume 8 Supplement Q
Sep 30, 2012
Volume 8 Supplement Q
View full issue


Key metrics

Suggested by Cory

CLINICAL RESEARCH

10.4244/EIJ-D-17-00421 Jan 19, 2018
TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model
Arsalan M et al
free

10.4244/EIJV13I13A241 Jan 19, 2018
The business of risk
Lennon R and Holmes D
free

10.4244/EIJV11SWA6 Sep 17, 2015
Measuring risk in valvular interventions: from low risk to futility
Kappetein A
free
Trending articles
318.1

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
116.5

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
72.15

State-of-the-art

10.4244/EIJ-D-22-00627 Feb 6, 2023
Left atrial appendage occlusion
Holmes D et al
free
68.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
49.55

CLINICAL RESEARCH

10.4244/EIJ-D-17-00962 Apr 6, 2018
A new optical coherence tomography-based calcium scoring system to predict stent underexpansion
Fujino A et al
free
43.45

State-of-the-Art Review

10.4244/EIJ-D-21-00145 Sep 20, 2021
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Beyar R et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved